-
Kiyomitsu Nemoto
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Takahiro Tanaka
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Ayaka Ikeda
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Sei Ito
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Masanori Mizukami
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Tokihiro Hikida
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka
-
Toshie Gamou
Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
-
Wataru Habano
Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
-
Shogo Ozawa
Department of Pharmacodynamics and Molecular Genetics, School of Pharmacy, Iwate Medical University
-
Kaoru Inoue
Division of Pathology, National Institute of Health Sciences
-
Midori Yoshida
Division of Pathology, National Institute of Health Sciences
-
Akiyoshi Nishikawa
Division of Pathology, National Institute of Health Sciences
-
Masakuni Degawa
Department of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka Global Center of Excellence (COE) Program, University of Shizuoka